Regional variation in incidence and prognosis of acute kidney injury
Nephrology Dialysis Transplantation · 2024
DOI: 10.1093/ndt/gfad267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Simon Kok Jensen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Acute Kidney Injury. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Aarhus University, Møller Foundation, Health Research Foundation of the Central Denmark Region.
Abstract (Originalsprache)
Background
Examining regional variation in acute kidney injury (AKI) and associated outcomes may reveal inequalities and possibilities for optimization of the quality of care. Using the Danish medical databases, we examined regional variation in the incidence, follow-up and prognosis of AKI in Denmark.
Methods
Patients with one or more AKI episodes in 2017 were identified using population-based creatinine measurements covering all Danish residents. Crude and sex-and-age-standardized incidence rates of AKI were estimated using census statistics for each municipality. Adjusted hazard ratios (aHR) of chronic kidney disease (CKD), all-cause death, biochemical follow-up and outpatient contact with a nephrology department after AKI were estimated across geographical regions and categories of municipalities, accounting for differences in demographics, comorbidities, medication use, lifestyle and social factors, and baseline kidney function.
Results
We identified 63 382 AKI episodes in 58 356 adults in 2017. The regional standardized AKI incidence rates ranged from 12.9 to 14.9 per 1000 person-years. Compared with the Capital Region of Denmark, the aHRs across regions ranged from 1.04 to 1.25 for CKD, from 0.97 to 1.04 for all-cause death, from 1.09 to 1.15 for biochemical follow-up and from 1.08 to 1.49 for outpatient contact with a nephrology department after AKI. Similar variations were found across municipality categories.
Conclusions
Within the uniform Danish healthcare system, we found modest regional variation in AKI incidence. The mortality after AKI was similar; however, CKD, biochemical follow-up and nephrology follow-up after AKI varied across regions and municipality categories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Aberdeen Centre for Health Data Science, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
- NHS Grampian, Aberdeen, UK.
- Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Simon Kok Jensen
Förderung
- Aarhus University
- Møller Foundation
- Health Research Foundation of the Central Denmark Region
- Independent Research Fund Denmark
Zitieren
APA
Jensen, S. K., Rasmussen, T. B., Jacobsen, B. H., Heide-Jørgensen, U., Sawhney, S., Gammelager, H., Birn, H., Johnsen, S. P., & Christiansen, C. F. (2024). Regional variation in incidence and prognosis of acute kidney injury. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad267
Vancouver
Jensen SK, Rasmussen TB, Jacobsen BH, Heide-Jørgensen U, Sawhney S, Gammelager H, et al. Regional variation in incidence and prognosis of acute kidney injury. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad267
BibTeX
@article{Jensen2024,
author = {Jensen, Simon Kok and Rasmussen, Thomas Bøjer and Jacobsen, Bjarke Hejlskov and Heide-Jørgensen, Uffe and Sawhney, Simon and Gammelager, Henrik and Birn, Henrik and Johnsen, Søren Paaske and Christiansen, Christian Fynbo},
title = {Regional variation in incidence and prognosis of acute kidney injury},
journal = {Nephrology Dialysis Transplantation},
year = {2024},
doi = {10.1093/ndt/gfad267}
}
EUVIMED